WO2010127420A9 - Sequências geneticamente modificadas de antígenos de plasmodium vivax - Google Patents
Sequências geneticamente modificadas de antígenos de plasmodium vivax Download PDFInfo
- Publication number
- WO2010127420A9 WO2010127420A9 PCT/BR2009/000130 BR2009000130W WO2010127420A9 WO 2010127420 A9 WO2010127420 A9 WO 2010127420A9 BR 2009000130 W BR2009000130 W BR 2009000130W WO 2010127420 A9 WO2010127420 A9 WO 2010127420A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- genetically modified
- plasmodium vivax
- antigens
- dbp
- sequences encoding
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 241000223810 Plasmodium vivax Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 108010057081 Merozoite Surface Protein 1 Proteins 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 101150078331 ama-1 gene Proteins 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2009/000130 WO2010127420A1 (pt) | 2009-05-05 | 2009-05-05 | Sequências geneticamente modificadas de antígenos de plasmodium vivax |
BRPI0924581A BRPI0924581A2 (pt) | 2009-05-05 | 2009-05-05 | seqüências geneticamente modificadas de antígenos de plasmodium vivax, composições vacinais contendo proteínas recombinantes e vírus recombinantes que expressam esses antígenos e método de vacinação dose-reforço contra malária |
CN2009801603910A CN102575256A (zh) | 2009-05-05 | 2009-05-05 | 编码间日疟原虫抗原的经遗传修饰的序列 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2009/000130 WO2010127420A1 (pt) | 2009-05-05 | 2009-05-05 | Sequências geneticamente modificadas de antígenos de plasmodium vivax |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010127420A1 WO2010127420A1 (pt) | 2010-11-11 |
WO2010127420A9 true WO2010127420A9 (pt) | 2010-12-29 |
Family
ID=43049863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2009/000130 WO2010127420A1 (pt) | 2009-05-05 | 2009-05-05 | Sequências geneticamente modificadas de antígenos de plasmodium vivax |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN102575256A (pt) |
BR (1) | BRPI0924581A2 (pt) |
WO (1) | WO2010127420A1 (pt) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001055181A2 (en) * | 2000-01-31 | 2001-08-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services, Centers For Disease Control And Prevention | Recombinant multivalent malarial vaccines against plasmodium vivax |
GB0706912D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel viral vaccines |
-
2009
- 2009-05-05 WO PCT/BR2009/000130 patent/WO2010127420A1/pt active Application Filing
- 2009-05-05 CN CN2009801603910A patent/CN102575256A/zh active Pending
- 2009-05-05 BR BRPI0924581A patent/BRPI0924581A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0924581A2 (pt) | 2016-07-19 |
WO2010127420A1 (pt) | 2010-11-11 |
CN102575256A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007027860A3 (en) | Adenoviral vector-based malaria vaccines | |
IL214460A0 (en) | Malaria prime/boost vaccines | |
JP2016146837A5 (pt) | ||
WO2018193063A3 (en) | NEW VACCINES AGAINST MALARIA AND ANTIBODIES BINDING PLASMODIUM SPOROZOIDS | |
MX347997B (es) | Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle. | |
EA201170812A1 (ru) | Способы и композиции для применения вакцины против кокцидиоза | |
PH12015500308A1 (en) | Hepatitis b virus core protein and surface antigen protein and vaccine comprising the same | |
MX2014009845A (es) | Vectores poxvirales recombinantes que expresan proteinas tanto de rabia como de ox40, y vacunas hechas a partir de los mismos. | |
WO2010019262A3 (en) | Polyvalent vaccine | |
MX2012002131A (es) | Modificacion de adenovirus recombinante con epitopes de proteina de circumsporozoito deplasmodium inmunogenico. | |
WO2013052859A3 (en) | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine | |
WO2015052543A3 (en) | Malaria vaccination | |
WO2011057254A3 (en) | Simian adenoviral vector-based vaccines | |
ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
PH12013501116A1 (en) | Raccoon poxvirus expressing rabies glycoproteins | |
MX2013003238A (es) | Regimen de vacunacion de sensibilizacion y refuerzo heterologo contra malaria. | |
WO2008086386A8 (en) | Adenoviral vector-based malaria vaccines | |
MX338052B (es) | Vectores de parapoxvirus que contienen el antigeno del virus de la rabia. | |
NZ596223A (en) | Combined measles-malaria vaccine | |
WO2010127420A9 (pt) | Sequências geneticamente modificadas de antígenos de plasmodium vivax | |
WO2015070207A3 (en) | Ama-1 epitopes, antibodies, compositions, and methods of making and using the same | |
WO2008118936A3 (en) | Method of elicting immune response with a modified mva viral hiv-1 vector | |
MX2010007876A (es) | Vectores virales recombinantes y composicion de vacuna para leishmaniasis. | |
WO2008027414A3 (en) | Novel p. falciparum vaccine proteins and coding sequences | |
WO2011133870A3 (en) | Vaccines comprising adenovirus vectors and signaling lymphocyte activating molecule-associated protein (sap) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980160391.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09844215 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9087/DELNP/2011 Country of ref document: IN |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09844215 Country of ref document: EP Kind code of ref document: A1 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI0924581 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI0924581 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111107 |